An Extension to Study MD7108240

Clinical trial NCT00733304 · COMPLETED

Trial details

NCT number: NCT00733304
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2008-06-25
Primary completion: 2009-09-09
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.